Inactive Instrument

News CurAegis Technologies, Inc. Other OTC

Equities

CRGS

US23127Q1022

Summary

Unlock all the news: Be the first to know and act before the market!

Involuntary Petition Approved for CurAegis Technologies, Inc.	31/08/21	CI
Involuntary Petition Filed Against CurAegis Technologies, Inc.	04/08/21	CI
CURAEGIS TECHNOLOGIES, INC. : Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement, Other Events (form 8-K)	19/03/21	AQ
CurAegis Announces Immediate Cessation of Operations	19/03/21	CI
CURAEGIS TECHNOLOGIES, INC. : Change in Directors or Principal Officers (form 8-K)	26/02/21	AQ
CurAegis Technologies, Inc. Announces Resignation of Aaron Newman as Director	26/02/21	CI
CURAEGIS TECHNOLOGIES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	12/01/21	AQ
CurAegis Technologies, Inc. announced that it has received $0.035 million in funding from Geneva Roth Remark Holdings, Inc.	05/01/21	CI
CURAEGIS TECHNOLOGIES, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	07/12/20	AQ
CURAEGIS TECHNOLOGIES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	30/11/20	AQ
CurAegis Technologies, Inc. announced that it has received $0.43 million in funding from Geneva Roth Remark Holdings, Inc.	18/11/20	CI
CurAegis Technologies, Inc. Announces Resignation of Phil Saunders as Director	17/11/20	CI
CURAEGIS TECHNOLOGIES, INC. : Change in Directors or Principal Officers (form 8-K)	17/11/20	AQ
CURAEGIS TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	13/11/20	AQ
Curaegis Technologies, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	13/11/20	CI
CurAegis Technologies, Inc. Announces the Resignation of Lance Drummond as Director	12/11/20	CI
CURAEGIS TECHNOLOGIES, INC. : Change in Directors or Principal Officers (form 8-K)	12/11/20	AQ
CURAEGIS TECHNOLOGIES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	26/10/20	AQ
CurAegis Technologies, Inc. announced that it has received $0.05 million in funding from Geneva Roth Remark Holdings, Inc.	18/10/20	CI
CURAEGIS TECHNOLOGIES, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/09/20	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News CurAegis Technologies, Inc. Other OTC

Equities

CRGS

US23127Q1022

Summary

Filters